Tumor localization of 16beta-[18F]-fluoro-5alpha-dihydrotestosterone versus [18F]-FDG in patients with progressive, metastatic prostate cancer. - Larson,SM.; Morris,M.; Gunther,I. (J Nucl Med, 2004)